Cogent Biosciences, Inc. COGT Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s other income (expense)?
- Cogent Biosciences, Inc. (COGT) reported other income (expense) of $6.26M in Q1 2026.
- How has Cogent Biosciences, Inc.'s other income (expense) changed year-over-year?
- Cogent Biosciences, Inc.'s other income (expense) increased by 112.2% year-over-year, from $2.95M to $6.26M.
- What is the long-term trend for Cogent Biosciences, Inc.'s other income (expense)?
- Over 3 years (2021 to 2024), Cogent Biosciences, Inc.'s other income (expense) has grown at a 83.0% compound annual growth rate (CAGR), from $3.28M to $20.08M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.